Condensed Consolidated Statements of Equity - USD ($) shares in Thousands, $ in Thousands		Total	Total	Common Stock	Additional Paid-in Capital	Treasury Stock	Retained Earnings	Accumulated Other Comprehensive Income (Loss)	Noncontrolling Interest	Cross currency swap	Cross currency swap Total	Cross currency swap Accumulated Other Comprehensive Income (Loss)	Interest rate swap	Interest rate swap Total	Interest rate swap Accumulated Other Comprehensive Income (Loss)
Balance (in shares) at Dec. 31, 2023				60,359
Balance at the start of the period at Dec. 31, 2023		$ 2,440,987	$ 2,315,427	$ 60	$ 1,614,769	$ (17,964)	$ 719,894	$ (1,332)	$ 125,560
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation		4,769	4,769		4,769
Exercise of stock-based awards by employees and directors (in shares)	[1]			63
Exercise of stock-based awards by employees and directors	[1]	55	55		55
Cash paid to noncontrolling interest		(2,587)							(2,587)
Cash dividend declared		(7,243)	(7,243)				(7,243)
Net income		40,511	38,587				38,587		1,924
Other comprehensive income (loss), net of related taxes:
Currency translation adjustments		(2,163)	(1,701)					(1,701)	(462)
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of an unconsolidated investment that qualifies as a cash flow hedge		510	510					510
Change in unrealized gains or losses in respect of a cross currency swap / interest rate swap derivative instrument that qualifies as a cash flow hedge										$ 561	$ 561	$ 561	$ 1,066	$ 1,066	$ 1,066
Other		53	53					53
Balance (in shares) at Mar. 31, 2024				60,422
Balance at the end of the period at Mar. 31, 2024		2,476,519	2,352,084	$ 60	1,619,593	(17,964)	751,238	(843)	124,435
Balance (in shares) at Dec. 31, 2023				60,359
Balance at the start of the period at Dec. 31, 2023		2,440,987	2,315,427	$ 60	1,614,769	(17,964)	719,894	(1,332)	125,560
Other comprehensive income (loss), net of related taxes:
Currency translation adjustments		(2,429)
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of an unconsolidated investment that qualifies as a cash flow hedge		939
Change in unrealized gains or losses in respect of a cross currency swap / interest rate swap derivative instrument that qualifies as a cash flow hedge													1,107
Other		25
Balance (in shares) at Jun. 30, 2024				60,453
Balance at the end of the period at Jun. 30, 2024		2,497,263	2,371,243	$ 61	1,624,763	(17,964)	766,137	(1,754)	126,020
Balance (in shares) at Mar. 31, 2024				60,422
Balance at the start of the period at Mar. 31, 2024		2,476,519	2,352,084	$ 60	1,619,593	(17,964)	751,238	(843)	124,435
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation		5,077	5,077		5,077
Exercise of stock-based awards by employees and directors (in shares)	[1]			31
Exercise of stock-based awards by employees and directors	[1]	94	94	$ 1	93
Cash paid to noncontrolling interest		(90)							(90)
Cash dividend declared		(7,344)	(7,344)				(7,344)
Net income		24,020	22,243				22,243		1,777
Other comprehensive income (loss), net of related taxes:
Currency translation adjustments		(266)	(164)					(164)	(102)
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of an unconsolidated investment that qualifies as a cash flow hedge		429	429					429
Change in unrealized gains or losses in respect of a cross currency swap / interest rate swap derivative instrument that qualifies as a cash flow hedge										(1,189)	(1,189)	(1,189)	41	41	41
Other		(28)	(28)					(28)
Balance (in shares) at Jun. 30, 2024				60,453
Balance at the end of the period at Jun. 30, 2024		2,497,263	2,371,243	$ 61	1,624,763	(17,964)	766,137	(1,754)	126,020
Balance (in shares) at Dec. 31, 2024				60,501
Balance at the start of the period at Dec. 31, 2024		2,550,932	2,425,129	$ 61	1,635,245	(17,964)	814,518	(6,731)	125,803
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation		4,911	4,911		4,911
Exercise of stock-based awards by employees and directors (in shares)	[1]			162
Exercise of stock-based awards by employees and directors	[1]	0
Cash paid to noncontrolling interest		(2,767)							(2,767)
Cash dividend declared		(7,273)	(7,273)				(7,273)
Net income		41,317	40,362				40,362		955
Other comprehensive income (loss), net of related taxes:
Currency translation adjustments		2,761	2,183					2,183	578
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of an unconsolidated investment that qualifies as a cash flow hedge		(896)	(896)					(896)
Change in unrealized gains or losses in respect of a cross currency swap / interest rate swap derivative instrument that qualifies as a cash flow hedge										(3,466)	(3,466)	(3,466)	(512)	(512)	(512)
Other		12	12					12
Balance (in shares) at Mar. 31, 2025				60,663
Balance at the end of the period at Mar. 31, 2025		2,585,019	2,460,450	$ 61	1,640,156	(17,964)	847,607	(9,410)	124,569
Balance (in shares) at Dec. 31, 2024				60,501
Balance at the start of the period at Dec. 31, 2024		2,550,932	2,425,129	$ 61	1,635,245	(17,964)	814,518	(6,731)	125,803
Other comprehensive income (loss), net of related taxes:
Currency translation adjustments		10,308
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of an unconsolidated investment that qualifies as a cash flow hedge		(1,110)
Change in unrealized gains or losses in respect of a cross currency swap / interest rate swap derivative instrument that qualifies as a cash flow hedge													(745)
Other		23
Balance (in shares) at Jun. 30, 2025				60,723
Balance at the end of the period at Jun. 30, 2025		2,618,788	2,492,948	$ 61	1,644,777	(17,964)	868,371	(2,297)	125,840
Balance (in shares) at Mar. 31, 2025				60,663
Balance at the start of the period at Mar. 31, 2025		2,585,019	2,460,450	$ 61	1,640,156	(17,964)	847,607	(9,410)	124,569
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation		4,621	4,621		4,621
Exercise of stock-based awards by employees and directors (in shares)	[1]			60
Exercise of stock-based awards by employees and directors	[1]	0
Cash dividend declared		(7,282)	(7,282)				(7,282)
Increase in noncontrolling interest related to tax monetization transaction		276							276
Net income		27,719	28,046				28,046		(327)
Other comprehensive income (loss), net of related taxes:
Currency translation adjustments		7,547	6,225					6,225	1,322
Change in unrealized gains or losses in respect of the Company's share in derivatives instruments of an unconsolidated investment that qualifies as a cash flow hedge		(214)	(214)					(214)
Change in unrealized gains or losses in respect of a cross currency swap / interest rate swap derivative instrument that qualifies as a cash flow hedge										$ 1,324	$ 1,324	$ 1,324	$ (233)	$ (233)	$ (233)
Other		11	11					11
Balance (in shares) at Jun. 30, 2025				60,723
Balance at the end of the period at Jun. 30, 2025		$ 2,618,788	$ 2,492,948	$ 61	$ 1,644,777	$ (17,964)	$ 868,371	$ (2,297)	$ 125,840

[1] Resulted in an amount lower than $1,000.